Recently, it was suggested that CDH11 acts as a tumor suppressor gene as demonstrated by its methylated and silenced status in malignant tissues such as in the nasopharyngeal, esophageal, gastric, hepatocellular carcinoma, colon, and breast carcinoma [26]. This evidence concerns the gene CDH11 and hepatocellular carcinoma.